|
|
|
|
Hemispherx is engaged in the clinical development of new drug entities for treatment of seriously debilitating disorders

Products
 
Alferon N Injection® is the only highly purified, natural-source, multispecies alpha interferon product currently approved in the U.S. and Argentina.
Learn More >>

 
R&D
 
Hemispherx’s platform technology includes components for potential treatment of various severely debilitating and life threatening diseases.
Discover More >>
 
Investors
 
Hemispherx is committed to providing information to shareholders, analysts, and potential investors.
Read More >>

 

News

Site Map | Privacy | Terms Of Use Copyright ©2016 Hemispherx Biopharma, Inc. | All Rights Reserved.